Literature DB >> 8169569

Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.

T H Kelly1, R W Foltin, C S Emurian, M W Fischman.   

Abstract

The effects of delta 9-tetrahydrocannabinol content of marijuana on cigarette smoking, dose choice, and verbal report of drug "liking" by adult males living in a residential laboratory were investigated. Marijuana cigarettes were available during programmed intervals while subjects were engaged in recreational activities. The tetrahydrocannabinol content of the cigarettes remained constant each day, but was changed across days. Subjects provided written ratings of drug liking at the end of each day. In the first study, placebo or active (2.3% delta 9-tetrahydrocannabinol) marijuana cigarettes were available for 1-, 2-, or 3-day intervals at varying times of day. The number of cigarettes smoked was unrelated to tetrahydrocannabinol content, although verbal reports of drug liking were consistently higher when marijuana cigarettes containing tetrahydrocannabinol were smoked. In a second study, a choice procedure, consisting of four 3-day blocks of 2 sample days and 1 choice day, was used. On sampling days, subjects smoked cigarettes varying in tetrahydrocannabinol content (0.0, 2.0, and 3.5%, w/w); on choice days they were allowed to choose between the two previously sampled doses. The number of cigarettes was not consistently related to tetrahydrocannabinol content. Ratings of drug liking were increased when marijuana cigarettes contained tetrahydrocannabinol, but ratings of marijuana containing 2.0% and 3.5% of the compound were similar. In contrast, subjects consistently chose the 3.5% dose over either the 0.0% or 2.0% dose. Dose choice was more sensitive to tetrahydrocannabinol content than either reports of drug liking or numbers of cigarettes smoked.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169569      PMCID: PMC1334408          DOI: 10.1901/jeab.1994.61-203

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  22 in total

Review 1.  Testing the abuse liability of anxiolytic and hypnotic drugs in humans.

Authors:  H de Wit; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1991-06       Impact factor: 4.492

Review 2.  Abuse liability studies of opioid agonist-antagonists in humans.

Authors:  K L Preston; D R Jasinski
Journal:  Drug Alcohol Depend       Date:  1991-06       Impact factor: 4.492

3.  Operant acquisition of marihuana in man.

Authors:  J H Mendelson; J C Kuehnle; I Greenberg; N K Mello
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

4.  The regularity of smoked marijuana self-administration.

Authors:  R W Foltin; M W Fischman; J V Brady; R M Capriotti; C S Emurian
Journal:  Pharmacol Biochem Behav       Date:  1989-02       Impact factor: 3.533

5.  Effects of smoked marijuana on heart rate, drug ratings and task performance by humans.

Authors:  T.H. Kelly; R.W. Foltin; M.W. Fischman
Journal:  Behav Pharmacol       Date:  1993-04       Impact factor: 2.293

6.  Delta-9-tetrahydrocannabinol content and human marijuana self-administration.

Authors:  L D Chait
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Self-administration of cocaine by humans: choice between smoked and intravenous cocaine.

Authors:  R W Foltin; M W Fischman
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

Review 8.  Health consequences of acute and chronic marihuana use.

Authors:  M O Maykut
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

9.  Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.

Authors:  L D Chait; J P Zacny
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans.

Authors:  R W Foltin; M W Fischman; P A Pippen; T H Kelly
Journal:  Drug Alcohol Depend       Date:  1993-04       Impact factor: 4.492

View more
  5 in total

1.  Amphetamine self-administration by humans: modulation by contingencies associated with task performance.

Authors:  S D Comer; M Haney; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Authors:  Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly
Journal:  J Clin Pharmacol       Date:  2010-07-29       Impact factor: 3.126

3.  Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.

Authors:  Carl L Hart; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

4.  Implications of behavioral pharmacology research for applied behavior analyses: JEAB's special issue celebrating the contributions of Joseph V. Brady (March 1994).

Authors:  K C Kirby; W K Bickel
Journal:  J Appl Behav Anal       Date:  1995

Review 5.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.